Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2010 1
2012 1
2013 1
2017 1
2018 4
2019 8
2020 10
2021 6
2022 2
2023 7
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for marcellino b[au]
Your search for Marcellini B[au] retrieved no results
Pharmacotherapy of Myelofibrosis.
Tremblay D, Marcellino B, Mascarenhas J. Tremblay D, et al. Among authors: marcellino b. Drugs. 2017 Sep;77(14):1549-1563. doi: 10.1007/s40265-017-0797-y. Drugs. 2017. PMID: 28791654 Review.
Mapping genotypes to chromatin accessibility profiles in single cells.
Izzo F, Myers RM, Ganesan S, Mekerishvili L, Kottapalli S, Prieto T, Eton EO, Botella T, Dunbar AJ, Bowman RL, Sotelo J, Potenski C, Mimitou EP, Stahl M, El Ghaity-Beckley S, Arandela J, Raviram R, Choi DC, Hoffman R, Chaligné R, Abdel-Wahab O, Smibert P, Ghobrial IM, Scandura JM, Marcellino B, Levine RL, Landau DA. Izzo F, et al. Among authors: marcellino b. Nature. 2024 May;629(8014):1149-1157. doi: 10.1038/s41586-024-07388-y. Epub 2024 May 8. Nature. 2024. PMID: 38720070
PPM1D inhibition may allow us to WIP leukemia.
Marcellino BK. Marcellino BK. Blood. 2023 Dec 14;142(24):2040-2042. doi: 10.1182/blood.2023021943. Blood. 2023. PMID: 38095924 No abstract available.
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.
Adegbite BO, Abramson MH, Gutgarts V, Musteata FM, Chauhan K, Muwonge AN, Meliambro KA, Salvatore SP, El Ghaity-Beckley S, Kremyanskaya M, Marcellino B, Mascarenhas JO, Campbell KN, Chan L, Coca SG, Berman EM, Jaimes EA, Azeloglu EU. Adegbite BO, et al. Among authors: marcellino b. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1175-1185. doi: 10.2215/CJN.0000000000000219. Epub 2023 Jun 29. Clin J Am Soc Nephrol. 2023. PMID: 37382967 Free PMC article.
Maintaining MOMENTUM in myelofibrosis.
Kremyanskaya M, Marcellino BK. Kremyanskaya M, et al. Among authors: marcellino bk. Lancet Haematol. 2023 Sep;10(9):e697-e699. doi: 10.1016/S2352-3026(23)00208-9. Epub 2023 Jul 27. Lancet Haematol. 2023. PMID: 37517412 No abstract available.
JAK inhibitors in the treatment of myelofibrosis.
Levavi H, Hoffman R, Marcellino BK. Levavi H, et al. Among authors: marcellino bk. Clin Adv Hematol Oncol. 2022 Jul;20(7):456-467. Clin Adv Hematol Oncol. 2022. PMID: 35802878 Review.
An MDM2 degrader for treatment of acute leukemias.
Marcellino BK, Yang X, Ümit Kaniskan H, Brady C, Chen H, Chen K, Qiu X, Clementelli C, Herschbein L, Li Z, Elghaity-Beckley S, Arandela J, Kelly B, Hoffman R, Liu J, Xiong Y, Jin J, Shih AH. Marcellino BK, et al. Leukemia. 2023 Feb;37(2):370-378. doi: 10.1038/s41375-022-01735-6. Epub 2022 Oct 29. Leukemia. 2023. PMID: 36309559 Free PMC article.
Alternatives to intensive treatment in patients with AML.
Himmelstein G, Mascarenhas J, Marcellino BK. Himmelstein G, et al. Among authors: marcellino bk. Clin Adv Hematol Oncol. 2021 Aug;19(8):526-535. Clin Adv Hematol Oncol. 2021. PMID: 34411072 Review.
44 results